Have a personal or library account? Click to login

In vitro evaluation of chitosan-DNA plasmid complex encoding Jembrana disease virus Env-TM protein as a vaccine candidate

Open Access
|Mar 2019

References

  1. 1. Budiarso I.T., Hardjosworo S.: Jembrana disease in Bali cattle. Aust Vet J 1976, 52, 97–97.10.1111/j.1751-0813.1976.tb13867.x
  2. 2. Burkala E.J., Narayani I., Hartaningsih N., Kertayadnya G., Berryman D.I., Wilcox G.E.: Recombinant Jembrana disease virus proteins as antigens for the detection of antibody to bovine lentiviruses. J Virol Methods 1998, 74, 39–46.10.1016/S0166-0934(98)00066-4
  3. 3. Chadwick B.J., Desport M., Brownlie J., Wilcox G.E., Dharma D.M.N.: Detection of Jembrana disease virus in spleen, lymph nodes, bone marrow and other tissues by in situ hybridization of paraffin-embedded sections. J Gen Virol 1998, 79, 101–106.10.1099/0022-1317-79-1-101
  4. 4. Chen H., Wilcox G., Kertayadnya G., Wood C.: Characterization of the Jembrana disease virus tat gene and the cis- and trans-regulatory elements in its long terminal repeats. J Virol 1999, 73, 658–666.10.1128/JVI.73.1.658-666.1999
  5. 5. Craigo J.K., Montelaro R.C.: Lessons in AIDS vaccine development learned from studies of equine infectious anemia virus infection and immunity. Viruses 2013, 5, 2963–2976.10.3390/v5122963
  6. 6. Ditcham W.G.F.: The development of recombinant vaccines against Jembrana disease, Murdoch University 2007, http://researchrepository.murdoch.edu.au/id/eprint/438.
  7. 7. Ditcham W.G.F., Lewis J.R., Dobson R.J., Hartaningsih N., Wilcox G.E., Desport M.: Vaccination reduces the viral load and the risk of transmission of Jembrana disease virus in Bali cattle. Virology 2009, 386, 317–324.10.1016/j.virol.2009.02.008
  8. 8. Gregory A.E., Titball R., Williamson D.: Vaccine delivery using nanoparticles. Front Cell Infect Microbiol 2013, 3, doi: 10.3389/fcimb.2013.00013.10.3389/fcimb.2013.00013
  9. 9. Haas J., Park E.C., Seed B.: Codon usage limitation in the expression of HIV-1 envelope glycoprotein. Curr Biol 1996, 6, 315–324.10.1016/S0960-9822(02)00482-7
  10. 10. Hartaningsih N., Wilcox G.E., Dharma D.M.N., Soetrismo M.: Distribution of Jembrana disease in cattle in Indonesia. Vet Microbiol 1993, 38, 23–29.10.1016/0378-1135(93)90072-F
  11. 11. Hashimoto M., Yang Z., Koya Y., Sato T.: Chitosan. In: Non-viral Gene Therapy: Gene Design and Delivery, edited by Taira K., Kataoka K., Niidome T., Springer-Verlag, Tokyo, Japan, 2005, pp. 63–74.10.1007/4-431-27879-6_6
  12. 12. Issel C.J., Horohov D.W., Lea D.F., Adams W.V., Hagius S.D., McManus J.M., Allison A.C., Montelaro R.C.: Efficacy of inactivated whole-virus and subunit vaccines in preventing infection and disease caused by equine infectious anemia virus. J Virol 1992, 66, 3398–3408.10.1128/jvi.66.6.3398-3408.19922411201316455
  13. 13. Kharia A.A., Singhai A.K., Verma R.: Formulation and evaluation of polymeric nanoparticles of an antiviral drug for gastroretention. Int J Pharm Pharm Sci 2012, 4, 1557–1562.10.37285/ijpsn.2011.4.4.6
  14. 14. Kusumawati A., Hidayat B., Sardjono B., Widada J.S.: Isolation-amplification of env-tm subunit genes of Jembrana disease virus by a single step RT-PCR and its direct cloning in pCR2.1-TOPO plasmid. Buletin Peternakan 2012, 27, 1–7, doi: 10.21059/buletinpeternak.v27i1.1459.10.21059/buletinpeternak.v27i1.1459
  15. 15. Leutenegger C.M., Hofmann-Lehmann R., Holznagel E., Cuisinier A.M., Wolfensberger C., Duquesne V., Cronier J., Allenspach K., Aubert A., Ossent P., Lutz, H.: Partial protection by vaccination with recombinant feline immunodeficiency virus surface glycoproteins. AIDS Res Hum Retroviruses 1998, 14, 275–283.10.1089/aid.1998.14.275
  16. 16. Martien R., Loretz B., Thaler M., Majzoob S., Bernkop-Schnürch A.: Chitosan – thioglycolic acid conjugate: an alternative carrier for oral nonviral gene delivery? J Biomed Mater Res A 2007, 82, 1–9.10.1002/jbm.a.31135
  17. 17. Masotti A., Bordi F., Ortaggi G., Marino F., Palocci C.: A novel method to obtain chitosan/DNA nanospheres and a study of their release properties, Nanotechnology 2008, 19, doi: https://doi.org/10.1088/0957-4484/19/05/055302.10.1088/0957-4484/19/05/055302
  18. 18. Pachuk C.J., McCallus D.E., Weiner, D.B., Satishchandran C.: DNA vaccines challenges in delivery. Current Curr Opin Mol Ther 2000, 2, 188–198.
  19. 19. Pearson L.D., Poss M.L., Demartini J.C.: Animal lentivirus vaccines: problems and prospects. Vet Immunol Immunopathol 1989, 20, 183–212.10.1016/0165-2427(89)90002-0
  20. 20. Siegert W., Nitsche A.: Guideline to reference gene selection for quantitative real-time PCR. Biochem Biophys Res Commun 2004, 313, 856–862.10.1016/j.bbrc.2003.11.177
  21. 21. Sinha V., Singla A., Wadhawan S., Kaushik R., Kumria R., Bansal K., Dhawan S.: Chitosan microspheres as a potential carrier for drugs. Int J Pharm 2004, 274, 1–33.10.1016/j.ijpharm.2003.12.026
  22. 22. Soeharsono S., Wilcox G.E., Dharma D.M.N., Hartaningsih N., Kertayadnya G., Budiantono A.: Species differences in the reaction of cattle to Jembrana disease virus infection. J Comp Pathol 1995, 112, 391–402.10.1016/S0021-9975(05)80020-9
  23. 23. Wang G., Pan L., Zhang Y.: Approaches to improved targeting of DNA vaccines. Hum Vac Immunother 2011, 7, 1271–1281.10.4161/hv.7.12.1798322108038
  24. 24. Wilcox G.E., Chadwick B.J., Kertayadnya G.: Recent advances in the understanding of Jembrana disease. Vet Microbiol 1995, 46, 249–255.10.1016/0378-1135(95)00089-S
  25. 25. Wilcox G.E., Soeharsono S., Dharma D.M.N., Copland J.W.: Jembrana disease and the bovine lentiviruses. Aciar Proc 1997, 75, 10–75.10.1111/j.1751-0813.1997.tb14379.x9258421
  26. 26. Williams J.A.: Vector design for improved DNA vaccine efficacy, safety, and production. Vaccines 2013, 1, 225–249.10.3390/vaccines1030225449422526344110
  27. 27. Winarti L., Martien R., Sismindari: Formulation of nanoparticles from short chain chitosan as gene delivery system and transfection against T47D cell line. Majalah Farmasi Indonesia 2011, 22, 204–211.
  28. 28. Xu K., Ling Z.Y., Sun L., Xu Y., Bian C., He Y., Lu W., Chen Z., Sun B.: Broad humoral and cellular immunity elicited by a bivalent DNA vaccine encoding HA and NP genes from an H5N1 virus. Viral Immunol 2011, 24, 45–56.10.1089/vim.2010.0056303463821319978
  29. 29. Ye Y., Xu Y., Liang W., Leung G.P.H., Cheung K., Zheng C., Chen F., Lam J.K.W.: Permeability across Calu-3 cells. J Drug Target 2013, 2330, 1–13.
  30. 30. Zhou J., Wang L., Lu G., Zhou A., Zhu M., Li Q., Wang Z., Arken M., Wang A., He S.: Epitope analysis and protection by a ROP19 DNA vaccine against Toxoplasma gondii. Parasite 2016, 23, 17.10.1051/parasite/2016017482487227055564
Language: English
Page range: 7 - 16
Submitted on: Sep 27, 2018
Accepted on: Mar 1, 2019
Published on: Mar 28, 2019
Published by: National Veterinary Research Institute in Pulawy
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2019 Januar Ishak, Lalu Unsunnidhal, Ronny Martien, Asmarani Kusumawati, published by National Veterinary Research Institute in Pulawy
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.